Research Article
Renal Recovery following Liposomal Amphotericin B-Induced Nephrotoxicity
Table 1
Baseline characteristics.
| | Characteristic | Included Patients N = 98 |
| | Underlying Disease | | | Hematological malignancy, n () | 53 (54) | | Allogeneic stem cell transplantation, n () | 14 (14) | | Autologous stem cell transplantation, n () | 4 (4) | | Solid Organ Transplant, n () | 9 (9) | | Heart, n () | 5 (5) | | Kidney, n () | 1 (1) | | Liver, n () | 2 (2) | | Lung, n () | 1 (1) | | Other, n () | 37 (37) | | Baseline Serum Creatinine, mg/dL | | | Mean (SD) | 0.8 (0.2) | | Median (IQR) | 0.7 (0.6-0.8) | | Pretreatment creatinine, mg/dL | | | Mean (SD) | 0.9 (0.3) | | Median (IQR) | 0.8 (0.7-1.0) | | Mean Estimated GFR (SD), mL/min/1.73m2 | 91.6 (21.2) |
|
|
Body mass index. Glomerular filtration rate, calculated by CKD-EPI. |